| The evolving druggability and developability space: chemically modified new modalities and emerging small molecules W Yang, P Gadgil, VR Krishnamurthy, M Landis, P Mallick, D Patel, ... The AAPS journal 22, 1-14, 2020 | 48 | 2020 |
| Enhanced brain delivery with lower hepatic exposure of lazaroid loaded nanostructured lipid carriers developed using a design of experiment approach P Gadgil, J Shah, DSL Chow International Journal of Pharmaceutics 544 (1), 265-277, 2018 | 16 | 2018 |
| Assessing the Utility ofIn VitroScreening Tools for PredictingBio-Performance of Oral Peptide Deliver P Gadgil, C Alleyne, KI Feng, M Hu, M Gindy, AV Buevich, S Fauty, ... Pharmaceutical Research 36 (151), 2019 | 14 | 2019 |
| Phosphaplatin anti-tumor effect enhanced by liposomes partly via an up-regulation of PEDF in breast cancer L Belkacemi, JL Atkins, LU Yang, P Gadgil, AK Sater, DS Chow, RN Bose, ... Anticancer Research 38 (2), 623-646, 2018 | 13 | 2018 |
| UPLC–MS/MS assay of 21-aminosteroid (lazaroid U74389G) for application in pharmacokinetic study P Gadgil, F Ibrahim, DSL Chow Journal of Pharmaceutical and Biomedical Analysis 122, 90-97, 2016 | 5 | 2016 |
| Lazaroid formulations for brain delivery in treatment of glioblastoma multiforme P Gadgil, DSL Chow, P New, J Shah Cancer Research 75 (15_Supplement), 4402-4402, 2015 | 1 | 2015 |
| The Evolving Druggability and Developability Space Part One: Druggability Part Two: Developability M Sanchez-Felix, W Yang, P Gadgil, M Landis, P Mallick, D Patel, ... Pharmaceutical research, 2020 | | 2020 |
| Lazaroid Formulations for Brain Delivery: Development of Nano-structured Lipid Carriers, Optimization, and Pharmacokinetic Evaluation P Gadgil | | 2016 |
| A comparative study between high potency dry powder inhalation and nebulized solution of vancomycin hydrochloride for lung delivery PS Gadgil Creighton University, 2011 | | 2011 |